Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark

Elisabeth Framke^*, Finn Sellebjerg, Matthias Kant, Morten Stilund, Henrik Boye Jensen, Zsolt Laszlo Illés, Nasrin Asgari, Tobias Sejbaek, Lena Christina Roug, Michael Broksgaard Jensen, Jakob Schäfer, Peter Vestergaard Rasmussen, Jeppe Romme Christensen, Arkadiusz Weglewski, Sivagini Prakash, Melinda Magyari, DMSG study group

^*Corresponding author for this work

IRS - Hospital Sønderjylland, Research Unit of Neurology (Sønderborg)
Department of Regional Health Research
IRS - Sygehus Lillebælt, Forskningsenhed for Neurologi (Kolding)
Department of Clinical Research
KI, OUH, Research unit of Neurology (Odense)
IRS - Næstved, Slagelse, Ringsted Hospitals (NSR), Research Unit of Neurology (Slagelse)
Neurobiology Research Unit
IRS - Esbjerg and Grindsted Hospital, Research Unit of Neurology (Esbjerg)

Copenhagen University Hospital
Gødstrup Hospital
Zealand University Hospital
Hillerød Hospital
Aalborg University Hospital
Aarhus University Hospital
University of Copenhagen
Regionshospitalet Viborg

Research output: Contribution to journal › Journal article › Research › peer-review

Sort by
Weight
Alphabetically

Risk of hypertension in patients with multiple sclerosis treated with teriflunomide compared to dimethyl fumarate: A nationwide cohort study in Denmark

Fingerprint

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience